Hyper Corporation

Hyper Corporation Net Margin

The Net Profit Margin of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is -0.41 %. In the previous year, Net Profit Margin was -137.45 % — a change of -99.70% (higher).

Net Margin

-0.41 %

YoY

-99.70%

Last updated:

Net Profit Margin of Hyper Corporation is 2025 -0.41 % . Net Profit Margin of Hyper Corporation was 2024 -137.45 % . It decreases by -99.70% higher compared to the previous year.

Hyper Corporation's net margin stands at -0.4%, up from -13.7% several years earlier.

The Hyper Corporation Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
-27.97 KRW
Jan 1, 2019
-10.22 KRW
Jan 1, 2020
-11.21 KRW
Jan 1, 2021
-13.72 KRW
Jan 1, 2022
-26.55 KRW
Jan 1, 2023
-4.57 KRW
Jan 1, 2024
-137.45 KRW
Jan 1, 2025
-0.41 KRW
The Hyper Corporation Net Margin history
YEARNet MarginYoY
-0.41 %-99.70%
-137.45 %+2,906.78%
-4.57 %-82.78%
-26.55 %+93.47%
-13.72 %+22.44%
-11.21 %+9.72%
-10.22 %-63.48%
-27.97 %-48.93%
-54.77 %+81.07%
-30.25 %+45.48%
-20.79 %-86.78%
-157.24 %+88,281.47%
-0.18 %+80.15%
-0.10 %-14.98%
-0.12 %-86.03%
-0.83 %+15.89%
-0.72 %+3.17%
-0.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Net Profit Margin of Hyper Corporation is -0.41 % in 2025.

Net Profit Margin of Hyper Corporation changed from -137.45 % to -0.41 %, representing a -99.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Hyper Corporation with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Hyper Corporation

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Hyper Corporation